After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...

The opening day of on-field drills at the 2026 NFL Scouting Combine in Indianapolis presented defensive linemen, edge rushers and linebackers at Lucas Oil Stadium, the home of the Indianapolis Colts.

1000-Lb. Sisters star Amy Lovvorn (née Slaton) has a whole new look — literally and figuratively. Lovvorn, 38, showed off the results of her eye surgery in a TikTok clip posted in July 2025, prior to ...

'1,000-Lb. Sisters' star Amy Slaton got married just 10 days after eye surgery, leading to an important request for her makeup artist in E! News' exclusive look at the season eight finale. 1000-Lb.

“My 600-lb Life” star Charity Pierce has died. She was 50. Pierce was in hospice care for at least a month before her death on Tuesday due to ongoing medical conditions, including lymphedema and fluid ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. China continues to expand its fast-growing navy—already the world's ...

LB Kitchen is a Portland-based all-day café and lifestyle brand known for its colorful bowls and superfood-packed hot and cold drinks. PHOTO / COURTESY JEN BRAVO LB Mini-Mart, the convenience store ...

Pauline Potter, known for appearing on season three of TLC reality show My 600-Lb. Life, has died at the age of 62. Pauline's son Dillon Brooks shared the news on YouTube, revealing that Pauline, who ...

“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

US-based biotech LB Pharmaceuticals has broken the 2025 biotech initial public offering (IPO) drought – and with style – raising $285m via a public listing on the US stock market. The company, which ...

Sept 11 (Reuters) - LB Pharmaceuticals' shares rose 27% in their Nasdaq debut on Thursday, giving the biotech firm a valuation of $381.9 million and opening the door for companies looking to tap the ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...